NCT05055271

Brief Summary

The objective of this study is to generate expert consensus statements on the differential diagnosis, definition, and management of EDS in patients with OSA who are adequately treated with primary therapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2021

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

September 7, 2021

Completed
17 days until next milestone

First Posted

Study publicly available on registry

September 24, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 12, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 12, 2022

Completed
Last Updated

October 10, 2023

Status Verified

October 1, 2023

Enrollment Period

1.4 years

First QC Date

September 7, 2021

Last Update Submit

October 5, 2023

Conditions

Keywords

Obstructive sleep apneaexcessive daytime sleepinessDelphi consensus

Outcome Measures

Primary Outcomes (1)

  • Consensus

    The level of agreement for all statements achieving consensus from the expert panel; consensus is predefined as ≥ 80% of the panel rating a given statement A+ or A.

    6 months

Study Arms (1)

Delphi panel

The Delphi panel will include 10 international experts in sleep and respiratory medicine. Two panelists will serve as co-chairs and eight panelists will serve as section leads for the major topic areas throughout the process. A series of planning sessions will be conducted with the co-chairs and section leads prior to implementation of the survey.

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Experts in sleep and respiratory medicine from North America and Europe

You may qualify if:

  • Members of the panel include experts in sleep and respiratory medicine in North American and Europe.

You may not qualify if:

  • Panelists who were not able to commit to all rounds of the modified Delphi process will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

King's College London

London, SE1 7EH, United Kingdom

Location

Related Publications (1)

  • Rosenberg R, Schweitzer PK, Steier J, Pepin JL. Residual excessive daytime sleepiness in patients treated for obstructive sleep apnea: guidance for assessment, diagnosis, and management. Postgrad Med. 2021 Sep;133(7):772-783. doi: 10.1080/00325481.2021.1948305. Epub 2021 Jul 22.

    PMID: 34292843BACKGROUND

MeSH Terms

Conditions

Sleep Apnea, ObstructiveDisorders of Excessive Somnolence

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Officials

  • Joerg Steier, PhD

    King's College London (KCL), UK

    STUDY CHAIR
  • Atul Malhotra, MD

    University of California San Diego (UCSD), USA

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Respiratory and Sleep Medicine

Study Record Dates

First Submitted

September 7, 2021

First Posted

September 24, 2021

Study Start

April 1, 2021

Primary Completion

September 12, 2022

Study Completion

September 12, 2022

Last Updated

October 10, 2023

Record last verified: 2023-10

Locations